An open labeled, randomized, controlled clinical study to evaluate the efficacy of Torchnil capsules and Febcin tablet as add-on therapy for Covid-19 patients

OBJECTIVES: This study was conducted to evaluate the efficacy and safety of Cap. Torchnil & Tab. Febcin when given as add-on therapy to Covid19 positive patients with moderate disease. MATERIAL AND METHODS: Following written informed consent, patients were randomized to receive Cap. Torchnil &am...

Descripción completa

Detalles Bibliográficos
Autores principales: Munshi, Renuka, Kumbhar, Dipti, Pawaskar, Pranesh, Rajadakshya, Girish, Palep, H.S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866077/
https://www.ncbi.nlm.nih.gov/pubmed/35228783
http://dx.doi.org/10.1016/j.jaim.2022.100559

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866077/
https://www.ncbi.nlm.nih.gov/pubmed/35228783
http://dx.doi.org/10.1016/j.jaim.2022.100559

Ejemplares similares